Skip to content
DataLookout
Menu

NCT07898475

In Vitro Susceptibility of Dermatophytes to Terbinafine and Itraconazole: MIC Distributions and Elevated-MIC Isolates in Faisalabad, Pakistan

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Proportion of Trichophyton isolates with elevated terbinafine MIC
Timeframe: Up to 7 weeks after specimen collection

Secondary (4)

Terbinafine MIC distribution, range, MIC50 and MIC90
Itraconazole MIC distribution, range, MIC50 and MIC90
Species distribution of dermatophyte isolates
Association of elevated terbinafine MIC with clinical variables

Arms and interventions

Patients with KOH-confirmed dermatophytosis

Consecutive dermatology outpatients of any age with clinically suspected, KOH-confirmed dermatophytosis. No intervention is given; clinical specimens are cultured and isolates undergo in vitro antifungal susceptibility testing.

Other: In vitro antifungal susceptibility testing

Sites

1 site in 1 country

  • Allied Hospital, Faisalabad Medical UniversityFaisalabad, Punjab Province, Pakistan